Guardian Pharmacy Services Reports Second Quarter 2025 Financial Results; Raises Full-Year Guidance

Guardian Pharmacy Services, Inc. (NYSE: GRDN), one of the nation's leading long-term care ("LTC") pharmacy services companies, announced today its financial results for the second quarter ended June ...

Why I Like Saipem7: Analyzing The Saipem-Subsea 7 Merger

The Subsea 7 S.A. and Saipem merger to form Saipem7 was overwhelmingly approved by shareholders, set to create a global ...

Rezolve Ai Raises 2025 Guidance to $150M ARR and Initiates 2026 Guidance to $500M ARR Exit Rate as Strong Growth Shatters Analyst Forecasts

M H1 Revenue (+426% YoY) vs. $5.1M Consensus Gross Margin at 95.8% vs. 60–70% ConsensusAdjusted EBITDA1 $(17.7)M vs. $(18.7)M Consensus 100+ ...

Why Nebius Could Be Worth $138 A Share After The Microsoft Deal

Discover why Nebius Group N.V. is gaining traction in AI infrastructure, with major contracts and growth catalysts ahead.